CN1223362C - Chinese medicine composition for treating colitis - Google Patents
Chinese medicine composition for treating colitis Download PDFInfo
- Publication number
- CN1223362C CN1223362C CN 02138144 CN02138144A CN1223362C CN 1223362 C CN1223362 C CN 1223362C CN 02138144 CN02138144 CN 02138144 CN 02138144 A CN02138144 A CN 02138144A CN 1223362 C CN1223362 C CN 1223362C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- parts
- radix
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a Chinese medicine composition for treating colitis, which is characterized in that the Chinese medicine composition comprises caryopteris incana, saussurea lappa clarke, fructus toosendan, heterophylla falsestarwort, stirred largehead atractylodes rhizome, Halloysitum Rubrum, etc. The Chinese herbal medicine, caryopteris incana, also called square stem lysimachia, is the main component in the formula. The caryopteris incana has the favorable functions of antisepsis anti-inflammation, heat and toxic material clearing, hemostasis, pain alleviating and pus and blood stool elimination in records. The formula has the advantages of reasonable combination, obvious curative effect, unique medicine selection and no obvious side and toxic effects. 86 clinical tests prove that the Chinese medicine composition takes effect on 93 % of patients who take the Chinese medicine composition for a first course, and the cure rate reaches 65.3%.
Description
Technical field
The present invention relates to Chinese medicine composition, exactly is the Chinese medicine composition of treatment colitis.
Background technology
Though chronic colitis, chronic ulcerative colitis are the highest with American-European countries's sickness rate; Also be the commonly encountered diseases of China, frequently-occurring disease.Wherein ulcerative colitis and intestinal cancer has a substantial connection, also becomes one of national healthy disease of harm.At present, healing clinically still acquires a certain degree of difficulty, and does not have specific drug, and easily outbreak repeatedly is one of common difficult disease.The report of relevant integrative therapy is a lot of in recent years, Western medicine is used antibiosis anti-inflammatory drugs such as salicylic acid sulfapyridine class, ofloxacin class, amoxicillin class always, though the part curative effect is arranged, radical rate is low, easily recurrence, wherein some Western medicine life-time service easily develops immunity to drugs and side effect.
The often unfixing prescription of Chinese traditional treatment, clinical many with heat-clearing and toxic substances removing, relieving diarrhea with astringents, regulating QI to relieve pain, invigorating the spleen to clear away damp pathogen, therapies such as blood circulation promoting and blood stasis dispelling, determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs often can alleviate partial symptoms, but produce effects is slower, need take medicine for a long time, radical rate is low, uses inconvenience, also imperfect therapy.Chinese patent medicine is used Spleen Invigorating and Intestine Tonifying Pill, JIECHANGYAN WAN, the intestines and stomach Yiganning capsule etc. always.
Summary of the invention
Through studying for a long period of time, provide the Chinese medicine composition of the treatment colitis that a kind of therapeutic effect is good, radical rate is high, have no side effect.
Drug regimen composition formula of the present invention following (herbal raw material with the quality proportioning is formed):
Herba caryopteridis nepetaefoliae 40～60 Radix Aucklandiae (Radix Vladimiriae) 5～15
Fructus Toosendan 5～15 Radix Pseudostellariaes 5～15
Rhizoma Atractylodis Macrocephalae (parched) 5～15 Halloysitum Rubrums 3～7
Rhizoma Zingiberis 3～7
The main component of the present invention's prescription is the Chinese herbal medicine Herba caryopteridis nepetaefoliae, the side of having another name called stalk Herba Lysimachiae, and tool is put down in writing this medicine good anti-inflammation, heat-clearing and toxic substances removing, hemostasis and pain-relieving, blood circulation promoting and blood stasis dispelling, reduce inflammatory exudation, eliminate bloody purulent stool, the reparation and the healing effect of cleaning and promotion intestinal mucosa ulcer surface.Adjuvant Radix Pseudostellariae invigorating the spleen and replenishing QI, nourishing YIN to lower pathogenic fire; The Halloysitum Rubrum astringing to arrest diarrhea; The Rhizoma Atractylodis Macrocephalae (parched) spleen reinforcing is good for the stomach, dampness removing and diarrhea-relieving; Fructus Toosendan, Radix Aucklandiae (Radix Vladimiriae) regulating QI to relieve pain, the effect of elimination abdominal distention; Rhizoma Zingiberis warming spleen and stomach for dispelling cold and stomach and alleviating pain, its effect warm in nature is compatible with single flower Herba caryopteridis nepetaefoliae's effect cool in nature, can send out better therapeutic.
Symptoms such as because of inflammatory stimulus, the patient has enterospasm, stomachache, times of defecation to increase, and it is more than to have loose bowels, Radix Aucklandiae (Radix Vladimiriae), Fructus Toosendan have regulating QI to relieve pain, eliminate the effect of stomachache, abdominal distention, alleviation intestinal colic.
The traditional Chinese medical science thinks that chronic diarrhea must be empty, thus with the Radix Pseudostellariae invigorating the spleen and replenishing QI, nourishing YIN to lower pathogenic fire, auxilliary Rhizoma Atractylodis Macrocephalae (parched) invigorating the spleen to clear away damp pathogen, Halloysitum Rubrum is held back intestinal antidiarrheal and is helped it.
Chinese medicine composition formula and prescription of the present invention is reasonable, and curative effect is more outstanding, selects medicine unique, no obvious toxic-side effects.Through 86 routine clinical verifications, 93% patient gets final product produce effects in first course of treatment of taking medicine, and cure rate reaches 65.3%.
The Chinese herbal medicine Herba caryopteridis nepetaefoliae is distributed more widely on the south the Changjiang river, aboundresources, but also establishing in large scale, and cultivation does not need special cultivation technique.All the other adjuvants are medicine commonly used.
The present invention can be made into capsule, and technology is simple, and is cheap for manufacturing cost.
The specific embodiment
Embodiment 1:
Take off the row raw material
Herba caryopteridis nepetaefoliae 400 Radix Aucklandiae (Radix Vladimiriae) 50
Fructus Toosendan 50 Radix Pseudostellariaes 50
Rhizoma Atractylodis Macrocephalae (parched) 50 Halloysitum Rubrums 30
Rhizoma Zingiberis 30
Pulverize and get final product in incapsulating after fine ground.Every capsules content of dispersion 0.5g.
Using method: oral, be grown up each 20, the child is cut down according to the circumstance, and three times on the one, one month is a course of treatment, and lapse on the state of an illness total course of treatment decides.
Embodiment 2:
Take off the row raw material
Herba caryopteridis nepetaefoliae 500 Radix Aucklandiae (Radix Vladimiriae) 70
Fructus Toosendan 70 Radix Pseudostellariaes 80
Rhizoma Atractylodis Macrocephalae (parched) 60 Halloysitum Rubrums 40
Rhizoma Zingiberis 40
Making capsule by example 1 gets final product.
Embodiment 3:
Take off the row raw material
Herba caryopteridis nepetaefoliae 600 Radix Aucklandiae (Radix Vladimiriae) 70
Fructus Toosendan 60 Radix Pseudostellariaes 80
Rhizoma Atractylodis Macrocephalae (parched) 70 Halloysitum Rubrums 60
Rhizoma Zingiberis 60
Making capsule by example 1 gets final product.
Claims (2)
1, the Chinese medicine composition of treatment colitis is characterized in that: be made up of the herbal raw material of following quality proportioning
5～15 parts of 40～60 portions of Radix Aucklandiae (Radix Vladimiriae) of Herba caryopteridis nepetaefoliae
5～15 parts of 5～15 parts of Radix Pseudostellariaes of Fructus Toosendan
3～7 parts of 5～15 parts of Halloysitum Rubrums of Rhizoma Atractylodis Macrocephalae (parched)
3～7 parts of Rhizoma Zingiberiss.
2, the Chinese medicine composition of treatment colitis according to claim 1 is characterized in that: the dosage form of described pharmaceutical composition is a capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02138144 CN1223362C (en) | 2002-08-17 | 2002-08-17 | Chinese medicine composition for treating colitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02138144 CN1223362C (en) | 2002-08-17 | 2002-08-17 | Chinese medicine composition for treating colitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1401378A CN1401378A (en) | 2003-03-12 |
| CN1223362C true CN1223362C (en) | 2005-10-19 |
Family
ID=4749311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02138144 Expired - Fee Related CN1223362C (en) | 2002-08-17 | 2002-08-17 | Chinese medicine composition for treating colitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1223362C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104623610A (en) * | 2015-02-26 | 2015-05-20 | 王燕 | Heat-clearing and dampness-resolving preparation for treating enteritis and preparation method thereof |
-
2002
- 2002-08-17 CN CN 02138144 patent/CN1223362C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1401378A (en) | 2003-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100336546C (en) | Chinese medicinal preparation for treating gastroenteric disease | |
| CN101468194B (en) | Medicine composition for treating colitis and method of making the same | |
| CN1239177C (en) | Chinese herbal medicine for treating piles | |
| CN1223362C (en) | Chinese medicine composition for treating colitis | |
| CN1857636A (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
| CN1179736C (en) | Chinese medicine for curing gastropathy | |
| CN1312085A (en) | Dermatosis treating medicine | |
| CN1049598C (en) | Chinese medicine prepn for psoriasis and its prepn | |
| CN1265818C (en) | Leech capsule | |
| CN1879771A (en) | Medicine for treating stomachache and method for preparing same | |
| CN1270755C (en) | Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN111789913A (en) | Traditional Chinese medicine compound preparation for treating salpingitis of laying hens and application | |
| CN1170571C (en) | Diles treating medicine and its prepn. | |
| CN1241626C (en) | Traditional Chinese medicine composition for treating rheumatic arthritis and atrophic arthritis | |
| CN1245211C (en) | Medicine for treating chronic gastritis and peptic ulcer | |
| CN1245178C (en) | Medicine for treating toothache | |
| CN1324633A (en) | Hyperosteogeny-treating capsule | |
| CN1105875A (en) | Medicine for treating ascites due to cirrhosis | |
| CN1299722C (en) | Chinese traditional medicine preparation for treating intestinal tract disease | |
| CN101130046A (en) | Chinese medicine for treating colonitis | |
| CN1927349A (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN1465357A (en) | Chinese patent drug for treating chronic gastritis and chronic gastric ulcer | |
| CN100335082C (en) | Medicine for treating rheumarthritis | |
| CN1130220C (en) | Chinese medicine 'Shexianfengshi wan' | |
| CN1205985C (en) | Medicine for curing chronic enteritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |